Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China.
Zhengwei LiuMingwu ZhangJianmei WangSonghua ChenBeibei WuLin ZhouAizhen PanWei-Bing WangXiaomeng WangPublished in: BioMed research international (2020)
This study highlights a high proportion of RMR-TB among new RR-TB cases in Zhejiang, China. The management of treatment with rapid and accurate diagnosis of MDR-TB other than only relying on RIF susceptibility testing is crucial for improving adherence and outcomes in patients with drug-resistant TB.